Zimmer Biomet to acquire Monogram Technologies for $177M

Monogram Technologies said its technologies combine 3D printing, advanced machine vision, AI, and next-generation robotics. | Source: Monogram Technologies

Zimmer Biomet Holdings, Inc. today announced that it is acquiring Monogram Technologies Inc., an orthopedic robotics company. The global medical technology developer will acquire all outstanding shares of Monogram for $4.04 a share, totaling an equity value of $177 million and an enterprise value of $168 million.

“Monogram’s technology is a major leap forward, demonstrating our commitment to becoming the boldest and broadest innovator in surgical robotics and navigation,” said Ivan Tornos, the chairman, president, and CEO of Zimmer Biomet. “Upon closing, our customer-centric portfolio will consist of the most comprehensive and flexible technology ecosystem to support the varying preferences of a vast array of surgeons — now and into the future.”

“With Monogram’s proprietary technology, Zimmer Biomet has the potential to become the first company to deliver fully autonomous capabilities and redefine both the standard of care and the future of orthopedic surgery,” he continued.

The respective boards of directors of Zimmer Biomet and Monogram unanimously approved the proposed transaction. Zimmer Biomet, which has offices in Montpelier, France, and Warsaw, Ind., offers its flagship ROSA platform. ROSA, which recently expanded into shoulder replacement, has four applications, including the knee.

Zimmer Biomet to incorporate Monogram tech into ROSA

Zimmer Biomet said it expects Monogram Technologies’ semi- and fully autonomous robotic technologies to add new and differentiated capabilities to expand its own surgical robot.

Monogram has developed a CT-based, semi-autonomous, AI-navigated total knee arthroplasty (TKA) robotic technology. It earned FDA 510(k) clearance in March 2025. The Austin, Texas-based company said it expects to commercialize the mBôs technology with Zimmer Biomet implants in early 2027.

In addition, Monogram is developing a fully autonomous version of the mBôs system. It asserted that the technology could significantly increase safety, efficiency, and outcomes, as well as address applications beyond TKA.

“Since our inception, we have been singularly focused on advancing orthopedic robotics with technology designed to safely, efficiently, and accurately support surgeons with total knee arthroplasty,” said Benjamin Sexson, CEO of Monogram. “We are thrilled by the opportunity to add our technology to Zimmer Biomet’s leading portfolio of surgical robotics, navigation solutions, and trusted implants and to benefit from their deep industry expertise and global scale.”

Zimmer Biomet said it expects the acquisition to contribute to revenue growth in 2027 and beyond. The company noted that mBôs will aid robotic knee adoption in the U.S., increase its market share with a broader product range, and expand its global knee offerings.

Zimmer Biomet to expand ROSA applications

The proposed transaction expands Zimmer Biomet’s extensive suite of orthopedic robotics. This gives it access to systems and analytics to address the needs of surgeons pre-, intra-, and post-operatively. The company said its portfolio includes:

• Imageless robotics through its ROSA platform
• A licensed CT-based handheld robot
• Mixed reality navigation
• AI-based surgical navigation
• A pathway to advanced semi- and fully autonomous robotics capabilities.

Zimmer Biomet predicted that it will be able to address the diverse preferences of surgeons globally and multiple styles of surgical techniques. This includes CT and non-CT, robotic and non-robotic, and manual, surgeon-centered methods, or semi- or fully autonomous technologies.

The ROSA platform is rapidly approaching 2,000 installations worldwide, the company claimed. Zimmer Biomet said it is committed to continuing to advance the ROSA platform and is investing in a robust R&D pipeline featuring several new products and software applications expected between now and 2027.

This includes ROSA Knee with OptimiZe, which has been submitted to the FDA, and 510(k) clearance is anticipated later this year, as well as ROSA Posterior Hip and the full commercial launch of ROSA Shoulder. Zimmer Biomet has also worked with THINK Surgical Inc. on integrating the Persona system with the TMINI surgical robot.

Keep track of your essentials with the Apple AirTag 4 Pack, the ultimate tracking solution for your belongings. With over 5,972 ratings and a stellar 4.7-star average, this product has quickly become a customer favorite. Over 10,000 units were purchased in the past month, solidifying its status as a highly rated Amazon Choice product.

For just $79.98, you can enjoy peace of mind knowing your items are always within reach. Order now for only $79.98 at Amazon!

Help Power Techcratic’s Future – Scan To Support

If Techcratic’s content and insights have helped you, consider giving back by supporting the platform with crypto. Every contribution makes a difference, whether it’s for high-quality content, server maintenance, or future updates. Techcratic is constantly evolving, and your support helps drive that progress.

As a solo operator who wears all the hats, creating content, managing the tech, and running the site, your support allows me to stay focused on delivering valuable resources. Your support keeps everything running smoothly and enables me to continue creating the content you love. I’m deeply grateful for your support, it truly means the world to me! Thank you!